Peking University-incubated Genskey provides high-sensitivity pathogen testing services in more than 20 Chinese provinces and municipalities.

Genskey, a China-based genetic testing services provider incubated at Peking University, has collected RMB230m ($34.4m) in a series C round led by private equity fund Huagai Capital, DealStreetAsia reported yesterday. The round was also backed by Legend Capital, the venture capital firm formed by conglomerate Legend Holdings, along with Apricot Capital and YuanBio Venture Capital.…

The rest of this content is only accessible to University Venturing: News, Data and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.